Synthetic molecule improves mitochondrial function in ALS models and patient-derived stem cells
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease in which motor neurons are gradually lost, leading to muscle weakness and, as the disease advances, difficulty breathing and swallowing. Existing medicines can slow disease progression to some extent, but no treatment has been established that fundamentally reverses the disease process. Mitochondrial dysfunction is…
Read original article on Medical Xpress - latest medical and health news stories →